等待開盤 11-26 09:30:00 美东时间
+0.730
+6.17%
Navient ( ($NAVI) ) just unveiled an update. On November 19, 2025, Navient Corp...
11-19 22:18
Navient (NASDAQ:NAVI) will host an audio webcast to provide an update on the progress on Phase 2 of its strategic transformation and discuss the growth strategy for its Earnest business on Wednesday, Nov. 19, 2025, at
11-12 22:21
Navient董事会批准了2025年第四季度每股0.16美元的股息,该股息将于12月19日支付,登记日为12月5日。
11-12 22:00
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
JP Morgan analyst Richard Shane maintains Navient (NASDAQ:NAVI) with a Neutral and lowers the price target from $14 to $12.5.
10-31 05:47
Navient shares are trading lower after the company reported worse-than-expected...
10-30 00:49
Navient (NASDAQ:NAVI) is looking for Q4 Adj EPS of $0.30-$0.35 vs $0.34 analyst estimate..
10-29 20:01
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Navient has been named a "Champion of Board Diversity" by The Forum of Executive Women for the 11th time, recognizing its commitment to gender diversity in leadership. This year, 54 companies in the Philadelphia region received the designation, marking a 46% increase over the past two years. The Forum, established in 1977, works to advance women into top roles, highlighting the growing impact of women in leadership.
10-27 12:00
Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it presented late-breaking Phase 2b
10-21 20:10